CERo Therapeutics Holdings ( (CERO)) has shared an update. On December 19, 2025, CERo Therapeutics Holdings, Inc. held a Special Meeting of Stockholders at which shareholders approved an amendment to ...
Hosted on MSN
CERo Therapeutics Enters New $14.6M Stock Agreement
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
MILAN--(BUSINESS WIRE)--As the 100-day countdown to the Olympic Winter Games continues, and in a year the global Corona brand is celebrating its 100 th anniversary, Corona Cero is officially set to ...
Trading of the Company's shares of common stock on Nasdaq will be suspended at the open of trading on October 31 CERo plans to appeal the Panel determination, seek trading of its shares on the OTC ...
Toronto commuters will get an early taste of Olympic excitement today as Corona Cero—the non-alcoholic offering of the popular beer—marks 100 days to the Olympic Winter Games with a downtown ...
Investing.com -- CERo Therapeutics (NASDAQ:CERO), a T cell therapy biotech company, is open to licensing deals or a potential sale while awaiting data on its lead asset, according to Axios, citing CEO ...
In the USA-Mexico rivalry, there's a scoreline that sends one fanbase into elation while irking the other. Whether it's in a high-stakes World Cup game or in a "friendly" match against El Tri, you’ll ...
Community driven content discussing all aspects of software development from DevOps to design patterns. Note, this article deals with client-side JavaScript. For a client and server-side JavaScript ...
CERo Therapeutics Holdings Inc (NASDAQ:CERO) shares are trading higher Tuesday after the company received U.S. Food and Drug Administration (FDA) Orphan Drug Designation for CER-1236. What Happened: ...
SOUTH SAN FRANSCISCO, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the ...
Fintel reports that on April 22, 2025, D. Boral Capital initiated coverage of CERo Therapeutics Holdings (NasdaqCM:CERO) with a Buy recommendation. There are 6 funds or institutions reporting ...
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community. Issues are used to track todos, bugs, feature requests, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results